THERAPEUTIC AGENT FOR HEPATOCELLULAR CARCINOMA
PROBLEM TO BE SOLVED: To provide a novel anticancer agent and therapeutic method having an excellent anticancer activity for hepatocellular carcinoma.SOLUTION: A therapeutic agent for hepatocellular carcinoma containing miriplatin and another therapeutic agent for hepatocellular carcinoma has a more...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PROBLEM TO BE SOLVED: To provide a novel anticancer agent and therapeutic method having an excellent anticancer activity for hepatocellular carcinoma.SOLUTION: A therapeutic agent for hepatocellular carcinoma containing miriplatin and another therapeutic agent for hepatocellular carcinoma has a more excellent anticancer activity by applying transcatherter arterial chemo-embolization (TACE) with respect to hepatocellular carcinoma. As another therapeutic agent for hepatocellular carcinoma, doxorubicin hydrochloride, epirubicin hydrochloride, mitomycin C, or 5-fluorouracil is preferable, with mitomycin C being the most preferable. Further, formation of platinum-DNA crosslinking with miriplatin can be promoted by a combined use of another therapeutic agent for hepatocellular carcinoma. |
---|